Larvol Delta - Cognition-Therapeutics-to-Host-Investor-Webcast-to-Discuss-Results-from-ProofofConcept-Phase-2-SHINE-Study-of-CT1812-in-MildtoModerate-Alzheimers-Disease-at-830am-ET-on-Monday-July-29-2024

Elayta (CT1812) - Cognition Therap

https://www.globenewswire.com/news-release/2024/07/26/2919863/0/en/Cognition-Therapeutics-to-Host-Investor-Webcast-to-Discuss-Results-from-Proof-of-Concept-Phase-2-SHINE-Study-of-CT1812-in-Mild-to-Moderate-Alzheimer-s-Disease-at-8-30am-ET-on-Monda.html

Jul 26, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next